Key facts
- Citation verified: Nature Medicine, volume 17, issue 2, pages 175-178, published online 30 January 2011 and in the February 2011 issue, DOI 10.1038/nm.2294, PMID 21278748.
- The paper has 17 authors; first author Atarashi R is listed at the Department of Molecular Microbiology and Immunology, Nagasaki University, and the last author is Nishida N.
- Co-authors include Satoh K, Kitamoto T, Klug G, McGlade A and Collins SJ.
- The assay detected at least 1 fg of abnormal prion protein in diluted CJD brain homogenate.
- Testing started in Japanese subjects and moved to a blinded study of 30 CSF specimens from Australia.
- The abstract reports greater than 80 percent sensitivity and 100 percent specificity, and concludes the test may improve diagnosis of suspected CJD during life.
- Europe PMC records the paper as not open access and not in PMC, with a free copy in the Nagasaki University repository (not opened here).
- A 2015 follow-on paper from the Caughey group describes an improved CSF RT-QuIC that flagged positives in 4 to 14 hours against 2.5 to 5 days for earlier tests, with 95.8 percent sensitivity and 100 percent specificity in its set, which places the 2011 assay as an early generation.
Timeline
- 2011Paper published online in Nature Medicine.
- 2011Appears in print, volume 17 issue 2, pages 175-178.
- 2015Improved CSF RT-QuIC reported in mBio with much shorter time to a positive result.
People
Last checked 1 November 2026